CLINICAL TRIAL HIGHLIGHTS - DYSKINESIA

J Parkinsons Dis. 2019;9(3):449-465. doi: 10.3233/JPD-199002.
No abstract available

Publication types

  • Review

MeSH terms

  • Antiparkinson Agents / adverse effects*
  • Clinical Trials as Topic
  • Dyskinesia, Drug-Induced / etiology
  • Dyskinesias / etiology*
  • Humans
  • Levodopa / adverse effects*
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / pathology*

Substances

  • Antiparkinson Agents
  • Levodopa

Associated data

  • ClinicalTrials.gov/NCT01336088
  • ClinicalTrials.gov/NCT02439125
  • ClinicalTrials.gov/NCT02617017
  • ClinicalTrials.gov/NCT02589340
  • ClinicalTrials.gov/NCT03956979
  • ClinicalTrials.gov/NCT03368170
  • ClinicalTrials.gov/NCT03922711